Lifting the Veil of Early-Stage Breast Cancer: The Intersection of Medical Oncology and Radiology
Lifting the Veil of Early-Stage Breast Cancer: The Intersection of Medical Oncology and Radiology
Lifting the Veil of Early-Stage Breast Cancer: The Intersection of Medical Oncology and Radiology
Lifting the Veil of Early-Stage Breast Cancer: The Intersection of Medical Oncology and Radiology

Lifting the Veil of Early-Stage Breast Cancer: The Intersection of Medical Oncology and Radiology

Regular price
Sale price
Regular price
Sold out
Unit price

Added to cart

Go to cart

  • 0.75 AMA PRA Category 1 Credits™
  • Video Online / On Demand
  • Certificate Included
  • Hatem Soliman, MD

This course is designed to provide radiologists with a comprehensive overview of the role of imaging in the management of breast cancer. We will discuss the importance of imaging in sequencing and appropriate regimen selection for all subtypes of breast cancer, including HR+HER2- BC, where genomic testing may be used in conjunction with imaging and pathology. We will also explore the use of MRI and PET imaging to assess disease burden in TBC and to identify patients who may benefit from neoadjuvant chemoimmunotherapy. Finally, we will discuss the potential of imaging to monitor disease response and adapt therapy accordingly through escalation/de-escalation strategies.


Hatem Soliman MD

Hatem Soliman MD

  • Assistant Professor
  • Department of Oncologic Sciences
  • USF Health Morsani College of Medicine
  • Associate
  • Moffitt Cancer Center

- Learn about advances in medical management of early-stage breast cancer

- Understand how imaging advances can affect management

- Explore escalation/de-escalation strategies incorporating imaging

  • Release Date: 1/03/2023
  • Expires after: 1/03/2026
  • Unlimited Access




Physicians (ACCME):

Efficiency Learning Systems, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Efficiency Learning Systems, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures

Hatem Soliman MD

Merck (promotional speaker)

AstraZeneca (consultant)

Novartis (consultant)

PUMA (consultant)

Seattle Genetics (consultant)

Faculty, planners, and others in a position to affect teaching content report to ELS all financial relationships with companies that are ineligible to be accredited in the ACCME System. (Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.)

An ELS review determines the relevance of all relationships to teaching content, and all relevant relationships are mitigated to prevent commercial bias and marketing in accredited continuing education. The absence of any relevant financial relationship will also be disclosed.


The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Unapproved Use Disclosure

Efficiency Learning Systems requires CME faculty (speakers) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may/will discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Privacy & Information

Efficiency Learning Systems has created a privacy policy to demonstrate our commitment to guarding the privacy of our clients. The following statements disclose our practices on gathering and disseminating information for this website.

Efficiency Learning Systems has security measures in place to protect the loss, misuse, and alteration of the information under our control. ELS does not share or sell any individual’s contact information, financial information, or unique identifiers to any commercial supporter, advertiser, or third party without the specific permission of the individual.

If you have any questions about this privacy policy, please contact ELS, at

Cancellation / Refund Policy

Efficiency Learning Systems reserve the right to cancel this activity due to unforeseen circumstances: registrants will receive refund of tuition charge paid as full liquidated damages.

The Efficiency Learning Systems Inc. (ELS) policy since 1995 is: Satisfaction guaranteed. The tuition charge paid by a participant will be refunded upon request.

You always receive the latest edition of any program, and automatically benefit from any enhancements that occur while you are participating in online offerings.